Actively Recruiting
Effect of a Structured Clinical and Pharmacological Management Strategy on Cardiovascular Risk Factors in Adult Patients in Routine Clinical Practice: A Pseudo-Experimental Before-and-After Study
Led by Universidad Católica San Antonio de Murcia · Updated on 2026-03-03
220
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating cardiovascular risk factors and clinical outcomes in adults attending an outpatient cardiology clinic. The study aims to identify predictors of adverse cardiovascular events, improve risk assessment, and enhance preventive care during routine clinical practice. Data collection will occur without changing participants' current treatments, focusing on a better understanding of cardiovascular risk profiles to support improved patient management. Participants will receive structured clinical and pharmacological management based on established guidelines. This includes regular assessments and adjustments of treatments for blood pressure, cholesterol, blood sugar, and lifestyle factors over a 120-day follow-up period. The intervention involves protocol-based management of antihypertensive, lipid-lowering, antidiabetic medications, and lifestyle recommendations. During the study, participants will undergo periodic evaluations of various health measures such as blood pressure, cholesterol levels, blood sugar, body weight, kidney function, and urine markers. These outcomes will be monitored from baseline to 90 days to assess changes. The study involves scheduled follow-up visits to track cardiovascular risk changes and ensure appropriate management, with a total participation duration extending over approximately four months.
CONDITIONS
Brief Title
Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Presence of at least one cardiovascular risk factor (hypertension, diabetes, dyslipidemia, obesity, or smoking)
- Receiving outpatient clinical follow-up
- Ability to provide informed consent
You will not qualify if you...
- Severe clinical instability requiring hospitalization
- Pregnancy
- End-stage renal disease or dialysis
- Inability to complete follow-up visits
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 120 days
Participants receive structured clinical follow-up with periodic assessment of cardiovascular risk factors and adjustment of pharmacological and lifestyle management according to current clinical guidelines.
Periodic visits over 120 days
Trial Site Locations
Total: 1 location
1
CDIEM Medical Center - Outpatient Cardiology Clinic
Santiago, Santiago Metropolitan, Chile
Actively Recruiting
Research Team
J
Julio César Núñez Farías, MD, MSc (Cardiology)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here